ICD-10 Code C83.33 | Diffuse large B-cell lymphoma, intra-abdominal lymph nodes Symptoms, Diagnosis, Billing

Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma characterized by the rapid proliferation of B-cells. When it involves intra-abdominal lymph nodes, it can lead to significant clinical complications, including abdominal pain, weight loss, and systemic symptoms. The ICD-10 Code C83.33 facilitates accurate diagnosis, documentation, and billing, ensuring proper treatment and public health reporting.

What is ICD-10 Code C83.33 for Diffuse large B-cell lymphoma, intra-abdominal lymph nodes?

ICD-10 Code C83.33 specifically denotes diffuse large B-cell lymphoma affecting intra-abdominal lymph nodes. This aggressive lymphoma type can present with various symptoms and requires prompt diagnosis and treatment. The code is utilized in clinical documentation and billing to ensure accurate representation of the patient's condition and to facilitate appropriate reimbursement for healthcare services.

ICD-10 Code C83.33 – Clinical Definition and Explanation of Diffuse large B-cell lymphoma, intra-abdominal lymph nodes

Diffuse large B-cell lymphoma is a hematological malignancy that arises from B-lymphocytes and can manifest in various anatomical locations, including intra-abdominal lymph nodes. The condition is often aggressive and necessitates immediate medical intervention to prevent progression and complications.

Key Clinical Features:

• Rapidly enlarging lymph nodes in the abdomen.
• Systemic symptoms such as fever, night sweats, and weight loss.
• Potential for abdominal pain or discomfort due to lymph node enlargement.
• Increased risk of complications such as bowel obstruction or perforation.

ICD-10 Code C83.33 for Diffuse large B-cell lymphoma, intra-abdominal lymph nodes – SOAP Notes & Clinical Use

ICD-10 Code C83.33 is integral in SOAP notes for documenting the patient's symptoms, assessment findings, and treatment plans. It is relevant in both acute and chronic care settings, ensuring comprehensive care and accurate billing.

What Does ICD-10 Code C83.33 for Diffuse large B-cell lymphoma, intra-abdominal lymph nodes Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C83.33 connects subjective patient reports and objective clinical findings to a formal diagnosis of diffuse large B-cell lymphoma affecting intra-abdominal lymph nodes. This code is essential for continuity of care, supporting billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C83.33 – Diffuse large B-cell lymphoma, intra-abdominal lymph nodes

Prompt treatment for diffuse large B-cell lymphoma is critical due to its aggressive nature. Hospitalization may be required for intensive therapy.

Antibiotic Therapy:

• Not applicable as DLBCL is not an infectious condition; treatment focuses on chemotherapy.
• R-CHOP regimen is commonly used, consisting of Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
• Alternative regimens may be considered based on patient-specific factors.

Supportive Care:

• Management of symptoms such as pain and nausea.
• Nutritional support to address weight loss.
• Psychosocial support for emotional well-being.

Infection Control:

• Standard precautions to prevent infections during chemotherapy.
• Monitoring for febrile neutropenia and prompt intervention if signs of infection arise.

How to Document Symptoms of Diffuse large B-cell lymphoma, intra-abdominal lymph nodes (ICD-10 C83.33) in SOAP Notes

Subjective:

• Patient reports abdominal pain and discomfort.
• History of unintentional weight loss over the past month.
• Complaints of night sweats and fatigue.
• No known allergies reported.

Objective:

• Abdominal examination reveals enlarged lymph nodes.
• Vital signs: Temperature 101°F, pulse 90 bpm, blood pressure 120/80 mmHg.
• Laboratory results show elevated lactate dehydrogenase (LDH).
• Imaging studies indicate significant lymphadenopathy in the abdomen.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Diffuse large B-cell lymphoma, intra-abdominal lymph nodes (ICD-10 Code C83.33)

Assessment:

• Diagnosis: Diffuse large B-cell lymphoma, intra-abdominal lymph nodes, Stage II.
• ICD-10 Code: C83.33.
• Contributing factors include advanced age and possible immunocompromised state.
• Patient presents with significant systemic symptoms.

Plan:

• Initiate R-CHOP chemotherapy regimen.
• Schedule follow-up appointments for monitoring treatment response.
• Educate the patient on potential side effects and supportive care measures.
• Arrange for nutritional counseling to address weight loss.

Treatment & Plan Section for ICD-10 Code C83.33 – Diffuse large B-cell lymphoma, intra-abdominal lymph nodes

• First-line treatment includes R-CHOP chemotherapy regimen.
• Consideration of clinical trials for advanced cases.
• Regular monitoring of blood counts and imaging studies.
• Patient education on symptom management and lifestyle modifications.

Using ICD-10 Code C83.33 for Diffuse large B-cell lymphoma, intra-abdominal lymph nodes in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings in SOAP notes.
• Utilize C83.33 in billing for chemotherapy and supportive care services.
• Maintain compliance with coding guidelines to support reimbursement.
• Document any complications or additional diagnoses that may affect treatment.

Related ICD-10 Codes Often Used with Diffuse large B-cell lymphoma, intra-abdominal lymph nodes

• C83.32 – Diffuse large B-cell lymphoma, extranodal sites
• C83.39 – Other diffuse large B-cell lymphoma

ICD-10 Code C83.33 in Medical Billing and Insurance for Diffuse large B-cell lymphoma, intra-abdominal lymph nodes

ICD-10 Code C83.33 is crucial for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings and treatment plans to support the ICD-10 claim.
• Use C83.33 in conjunction with chemotherapy administration codes.
• Ensure that all documentation aligns with payer requirements for reimbursement.
• Include detailed notes on patient education and follow-up care.

Common CPT Pairings: